Estimating coverage of the National HPV Vaccination Program: where are we at?

Julia M L Brotherton and Robyn M Mullins
Med J Aust 2009; 191 (3): . || doi: 10.5694/j.1326-5377.2009.tb02738.x
Published online: 3 August 2009

To the Editor: Australia’s world-leading government-funded National Human Papillomavirus (HPV) Vaccination Program for women aged 12–26 years is made up of two components: an ongoing school-based program and a time-limited catch-up program delivered through schools, general practices and community vaccination services. The catch-up program started in April 2007 and was due to finish by July 2009, but has been extended to 31 December 2009 to allow women to complete the three-dose schedule.

  • 1 National HPV Vaccination Program Register and Victorian Cervical Cytology Registry, Victorian Cytology Service, Melbourne, VIC.
  • 2 Centre for Behavioural Research in Cancer, Cancer Council Victoria, Melbourne, VIC.



We thank Jenny Anderson, Natalie Herd and Carol Chenco for their work on the telephone survey.

Competing interests:

PapScreen Victoria funded the telephone survey. Julia Brotherton has previously been involved with epidemiological studies of HPV in which some unrestricted funding was received from GlaxoSmithKline and CSL, and HPV testing of samples was provided by Merck through funding by CSL.

  • 1. Australian Institute of Health and Welfare. Cervical screening in Australia 2005–2006. Canberra: AIHW, 2008. (Cancer Series No. 41; AIHW Cat. No. CAN 36.)
  • 2. Brotherton JML, Deeks SM, Campbell-Lloyd S, et al. Interim estimates of human papillomavirus vaccination coverage in the school-based program in Australia. Commun Dis Intell 2008; 32: 457-461.
  • 3. Information for health professionals. Melbourne: National HPV Vaccination Program Register. (accessed Jul 2009).


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.